Literature DB >> 28221262

Recent Advances in Computed Tomographic Technology: Cardiopulmonary Imaging Applications.

Azadeh Tabari1, Roberto Lo Gullo, Venkatesh Murugan, Alexi Otrakji, Subba Digumarthy, Mannudeep Kalra.   

Abstract

Cardiothoracic diseases result in substantial morbidity and mortality. Chest computed tomography (CT) has been an imaging modality of choice for assessing a host of chest diseases, and technologic advances have enabled the emergence of coronary CT angiography as a robust noninvasive test for cardiac imaging. Technologic developments in CT have also enabled the application of dual-energy CT scanning for assessing pulmonary vascular and neoplastic processes. Concerns over increasing radiation dose from CT scanning are being addressed with introduction of more dose-efficient wide-area detector arrays and iterative reconstruction techniques. This review article discusses the technologic innovations in CT and their effect on cardiothoracic applications.

Entities:  

Mesh:

Year:  2017        PMID: 28221262     DOI: 10.1097/RTI.0000000000000258

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  3 in total

1.  Comparison study of image quality at various radiation doses for CT venography using advanced modeled iterative reconstruction.

Authors:  Jung Han Hwang; Jin Mo Kang; So Hyun Park; Suyoung Park; Jeong Ho Kim; Sang Tae Choi
Journal:  PLoS One       Date:  2021-08-31       Impact factor: 3.240

2.  Inter-observer agreement of the Coronary Artery Disease Reporting and Data System (CAD-RADSTM) in patients with stable chest pain.

Authors:  Ahmed Abdel Khalek Abdel Razek; Mohamed Magdy Elrakhawy; Mahmoud Mohamed Yossof; Hadeer Mohamed Nageb
Journal:  Pol J Radiol       Date:  2018-04-16

3.  More holes, more contrast? Comparing an 18-gauge non-fenestrated catheter with a 22-gauge fenestrated catheter for cardiac CT.

Authors:  Andreas Marco Fischer; Philipp Riffel; Thomas Henzler; U Joseph Schoepf; Andres F Abadia; Richard Robert Bayer; Holger Haubenreisser; Dante Giovagnoli; Alexander Kremer; Stefan O Schoenberg; Joshua Gawlitza
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.